Table A3.

p-values of significance of relationship between medical therapies potentially influencing platelet state and miRNA relative plasma levels obtained by MLR analysis in a combined HT+SCAD+ACS group (n = 106). ACEI, angiotensin-converting enzyme inhibitors.

miRNA	miR- 126-3p	miR- 145-5p	miR- 146a-5p	miR- 155-5p	miR- 17-5p	miR- 21-5p	miR- 375-3p	miR- 92a-3p
Beta-blockers	0.932	0.932	0.932	0.254	0.126	0.468	0.760	0.887
Calcium channel blockers	0.889	0.889	0.889	0.889	0.889	0.889	0.889	0.889
Nitrates	0.184	0.272	0.116	0.116	0.130	0.116	0.599	0.932
ACEI	0.653	0.994	0.994	0.994	0.994	0.994	0.014	0.994
Diuretics	0.996	0.996	0.728	0.996	0.996	0.210	0.512	0.996
Antiplatelet drugs	0.351	0.572	0.351	0.529	0.604	0.572	0.529	0.529
Anticoagulants	0.424	0.924	0.540	0.424	0.424	0.424	0.891	0.038
Statins	0.366	0.366	0.366	0.366	0.366	0.426	0.366	0.366